Minnesota Telemedicine Laws: Licensure, Prescribing, Parity

Minnesota does two things most states do not. It lets an out-of-state physician treat Minnesota patients without a Minnesota license, through an annual registration that predates the telehealth boom by two decades. And it requires commercial payers to pay telehealth at the in-person rate, with no expiration attached. The constraint sits where most people do not look — a rule in the pharmacy chapter about examinations that makes Minnesota one of the harder states for remote controlled-substance prescribing.

Licensure: register, or get licensed

Minn. Stat. § 147.081 makes it unlawful to practice medicine in Minnesota unless the person holds a Minnesota license or is registered to provide interstate telehealth under § 147.032. That second clause is the whole story. A physician licensed without restriction in the state from which the physician provides telehealth services, who has never had a license revoked or restricted anywhere, may treat patients located in Minnesota by registering annually with the Board of Medical Practice — disclosing every current and former license and every negative licensing action, paying an application and annual fee, and submitting to Minnesota law and the Board. A registrant must immediately notify the Board of any restriction later placed on a license in any state or jurisdiction.

The lane is telehealth-only, and the statute draws it tightly: a registrant "does not open an office in this state, does not meet with patients in this state, and does not receive calls in this state from patients." Any Minnesota footprint requires a license. Three situations skip registration (they waive only the annual registration, not the other conditions): care for an emergency medical condition; care provided on an irregular or infrequent basis, which the statute defines concretely as less than once a month or fewer than ten patients annually; and consultations in which a Minnesota-licensed physician retains ultimate authority over diagnosis and care. Most states leave "irregular" to the imagination.

Minnesota is a full Interstate Medical Licensure Compact member, effective July 1, 2015 under SF 253, so expedited licensure is available when the registration lane is too narrow. Our cross-state licensing tracker records Minnesota as outside the Physical Therapy Licensure Compact; Minnesota is a PSYPACT participating state and one of the nine states where Counseling Compact privileges are live, but it is not a Nurse Licensure Compact state — a nurse treating Minnesota patients needs a Minnesota license.

Prescribing: the relationship is easy, the examination is not

Minn. Stat. § 147.033 is two sentences of good news: a physician-patient relationship "may be established through telehealth," and a physician practicing by telehealth is held to the same standards of practice and conduct as in person. No prior in-person visit is needed.

Then § 151.37, subd. 2 changes the math for a specific drug list. A prescription drug order is not valid — for controlled substances in Schedules II through IV and substances the Board of Pharmacy has designated as controlled under § 152.02, subds. 7, 8, and 12, muscle relaxants, centrally acting analgesics with opioid activity, drugs containing butalbital, or PDE5 inhibitors used to treat erectile dysfunction — unless it rests on a documented patient evaluation "including an examination." All five routes rest on an in-person examination: by the prescriber at the time of the order, by the prescriber previously, by another prescriber in the same group or clinic, by a consultant to whom the patient was referred, or, when a consultant prescribes by telehealth, by the referring practitioner (§ 151.37, subd. 2(e)(1)). A telehealth examination stands alone in only two cases: PDE5 inhibitors for erectile dysfunction, and medications for opioid use disorder (subd. 2(e)(2)).

Stimulants, benzodiazepines, and opioid analgesics therefore need an in-person examination somewhere in the chain. For telepsychiatry built on a fully remote model, that is the binding constraint, and it binds whatever federal policy allows. Our DEA prescribing report tracks the federal side.

The other state duties:

• Prescription monitoring. Under § 152.126, subd. 6(c), every prescriber licensed by a Minnesota health-related licensing board and practicing in the state who is authorized to prescribe controlled substances for humans and holds a current DEA registration must register for and keep a Prescription Monitoring Program account. Under subd. 6(d), the prescriber or a delegate must check the PMP before issuing an initial prescription for a Schedule II through IV opiate, and at least once every three months for patients receiving an opiate for chronic pain or in medication-assisted treatment for opioid addiction. Subdivision 6(e) lists nine exceptions: palliative, hospice, or other end-of-life care; pain from cancer or its treatment; a non-refillable supply of five days or less; a provider-patient relationship longer than one year; a prescription within 14 days after surgery or three days after oral surgery, or one that follows the protocols of the state's opioid prescribing improvement program; an inpatient hospital admission; a drug the prescriber or a pharmacist administers, or the patient takes at the prescriber's direction in the presence of the prescriber or pharmacist; a medical emergency that makes a check impossible before prescribing; and a PMP failure the prescriber reports to the Board of Pharmacy.
• Opioid limit. Section 152.11, subd. 4 limits prescriptions of opiates or narcotic pain relievers in Schedules II through IV for acute pain to a seven-day supply for an adult and a five-day supply for a minor under 18, and to a four-day supply for acute dental pain (including wisdom-tooth extraction) or acute pain associated with refractive surgery. Acute pain does not include chronic pain or pain treated as part of cancer care, palliative care, or hospice or other end-of-life care. A practitioner may prescribe more when, in the practitioner's professional clinical judgment, more is required to treat the patient's acute pain.
• E-prescribing. Since January 1, 2011, § 62J.497, subd. 2(a) has required every prescriber to establish, maintain, and use an electronic prescription drug program, and subd. 3 requires the NCPDP SCRIPT standard. Under § 152.11, subd. 1(b), an electronic prescription for a Schedule II, III, IV, or V controlled substance is void unless it meets those standards and the federal electronic-prescription rules in 21 CFR parts 1300, 1304, 1306, and 1311. We found no Minnesota electronic-prescribing mandate aimed at controlled substances: § 152.11 still sets rules for written, oral, and faxed controlled-substance prescriptions, and § 62J.497 lists no controlled-substance exceptions. Medicare Part D separately requires at least 70 percent of Part D Schedule II–V prescriptions to be electronic under 42 CFR 423.160, subject to exceptions and waivers.
• State registration. Minnesota issues no separate state controlled-substance registration for prescribers; the Board of Pharmacy registration in § 152.12, subd. 3 covers research use. Section 152.12, subd. 1 authorizes licensed physicians, advanced practice registered nurses, physician assistants, and certain other practitioners to prescribe Schedule II through V substances, and § 152.11 requires Schedule II through IV prescriptions to come from a prescriber with a current DEA registration number. The PMP account is the state step.

Federal law adds a separate layer for controlled substances. Under the temporary rule DEA and HHS published December 31, 2025 (90 FR 61301), which runs through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter without a prior in-person evaluation, when the rule's other conditions are met; audio-only encounters qualify only for Schedule III–V narcotic medications approved by the FDA to treat opioid use disorder. See our guide to federal telehealth laws.

Consent: no single telehealth statute

Minnesota has no general telehealth consent mandate. Neither § 62A.673 nor the Medicaid telehealth statute addresses it. What exists is service-specific: a person receiving targeted case management has a statutory right to choose and consent to interactive video and to refuse it at any time, and a substance use disorder counselor may document verbal or electronic approval of a treatment plan in place of a signature. Minors have their own rule: under § 144.343, subd. 1, any minor may consent to services to determine the presence of or to treat pregnancy, venereal disease, and alcohol and other drug abuse, and no one else's consent is required. General informed-consent obligations still apply — there is simply no Minnesota telehealth consent form to build into intake.

Medicaid: parity in the statute, audio-only on a clock

Subdivision 3b of § 256B.0625 is short and generous. Medical assistance covers medically necessary services and consultations delivered by telehealth "in the same manner as if the service or consultation was delivered through in-person contact," and those services "shall be paid at the full allowable rate." Store-and-forward sits inside the statutory definition, and telehealth can satisfy the face-to-face requirement in payment methods for federally qualified health centers, rural health clinics, tribal clinics, and certified community behavioral health clinics.

Audio-only is covered from July 1, 2025 to July 1, 2027 by the statute's own terms, billed with modifier 93 — a deadline written into the definition rather than a policy preference. Payment is conditioned on per-visit documentation — service, times, the basis for judging telehealth appropriate, the transmission mode, both site locations — and on a provider self-attestation filed with DHS before billing.

Telemonitoring is separate, under subd. 3h, and narrower: covered when the service is medically appropriate, the provider has documented that it would likely prevent a hospital or nursing facility admission, the recipient or a caregiver can operate the device, and no health care staff are on site. More in our remote patient monitoring guide.

Private insurance: payment parity, and it did not sunset

This is where secondary reporting goes wrong. Section 62A.673, subd. 5, requires a health carrier to reimburse for telehealth "on the same basis and at the same rate" it would apply to the same service in person, and bars denying or limiting reimbursement based on delivery method or technology. Value-based arrangements are carved out. The current statute attaches no expiration date to subd. 5.

The July 1, 2025 sunset that circulated widely applied to something else — audio-only communication inside the Act's definition of "telehealth" at subd. 2(h), which counts audio-only as telehealth only for a scheduled appointment where the standard of care can be met by audio-only, or for mental health or substance use disorder services the enrollee initiates in an emergency or crisis when a scheduled appointment was not possible. The 2025 Legislature extended that to July 1, 2027. An older sunset did take effect: subd. 6(b), the audio-only equipment-coverage paragraph, expired July 1, 2023, which is why audio-only now lives in the definition. Coverage parity, prior-authorization and utilization-review symmetry, and a ban on telehealth-only networks round out the Act, which does not reach state public health care program enrollees. A carrier may require prior authorization for a telehealth service only if it requires prior authorization for the same service in person, and any utilization review must be conducted in the same manner and use the same clinical review criteria as for in-person care (subd. 4(b)–(c)). Its limits matter too: coverage runs through the provider network available under the enrollee's plan (subd. 3(b)); carriers need not cover services that are not medically necessary or not covered; and carriers may use reasonable medical management techniques, safety-or-efficacy criteria for services they do not already pay others to deliver by telehealth, and anti-fraud documentation rules that are not unduly burdensome (subd. 3(e)). Our reimbursement guide explains how parity states differ in practice.

What to watch

One date and two gaps. The audio-only authorizations in both the Telehealth Act and the Medicaid statute expire July 1, 2027 unless the Legislature acts again; a practice built on telephone visits should plan for that now. The examination rule in § 151.37 is most likely to be revisited as federal controlled-substance policy settles. And § 147.032 is a physician-only lane — other professions rely on their own compacts and exceptions. Verify current requirements with the Minnesota Board of Medical Practice and the Department of Human Services before acting, and compare Minnesota with its neighbors in the national overview.